1. Home
  2. CASS vs OMER Comparison

CASS vs OMER Comparison

Compare CASS & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cass Information Systems Inc

CASS

Cass Information Systems Inc

N/A

Current Price

$56.40

Market Cap

714.9M

ML Signal

N/A

Logo Omeros Corporation

OMER

Omeros Corporation

HOLD

Current Price

$19.27

Market Cap

844.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASS
OMER
Founded
1906
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
714.9M
844.6M
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
CASS
OMER
Price
$56.40
$19.27
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$45.00
$32.50
AVG Volume (30 Days)
61.2K
2.3M
Earning Date
04-23-2026
05-14-2026
Dividend Yield
2.75%
N/A
EPS Growth
87.77
98.15
EPS
1.48
0.77
Revenue
$190,750,000.00
$29,868,000.00
Revenue This Year
$0.81
N/A
Revenue Next Year
$4.39
$233.22
P/E Ratio
$38.44
$24.19
Revenue Growth
N/A
N/A
52 Week Low
$36.07
$3.94
52 Week High
$59.63
$18.89

Technical Indicators

Market Signals
Indicator
CASS
OMER
Relative Strength Index (RSI) 56.85 85.98
Support Level $51.00 $9.12
Resistance Level N/A N/A
Average True Range (ATR) 1.54 0.85
MACD -0.31 0.51
Stochastic Oscillator 65.10 94.80

Price Performance

Historical Comparison
CASS
OMER

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution, and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. Additionally, the firm has a banking subsidiary, offering banking services mainly to privately held businesses in the St. Louis metropolitan area and restaurant franchises and faith-based ministries within the United States. The company operates in two reportable segments: Information Services, which generates the maximum revenue, and Banking Services.

About OMER Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

Share on Social Networks: